122 related articles for article (PubMed ID: 30559853)
1. Moxifloxacin in the Outpatient Treatment of Moderate Exacerbations of Chronic Obstructive Pulmonary Disease.
Minov J; Stoleski S; Petrova T; Vasilevska K; Mijakoski D; Bislimovska-Karadzhinska J
Open Access Maced J Med Sci; 2018 Nov; 6(11):2017-2022. PubMed ID: 30559853
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Poole P
Cochrane Database Syst Rev; 2013 Nov; (11):CD009764. PubMed ID: 24288145
[TBL] [Abstract][Full Text] [Related]
3. Zabofloxacin versus moxifloxacin in patients with COPD exacerbation: a multicenter, double-blind, double-dummy, randomized, controlled, Phase III, non-inferiority trial.
Rhee CK; Chang JH; Choi EG; Kim HK; Kwon YS; Kyung SY; Lee JH; Park MJ; Yoo KH; Oh YM
Int J Chron Obstruct Pulmon Dis; 2015; 10():2265-75. PubMed ID: 26543359
[TBL] [Abstract][Full Text] [Related]
4. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
5. Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice.
Sachs AP; Koëter GH; Groenier KH; van der Waaij D; Schiphuis J; Meyboom-de Jong B
Thorax; 1995 Jul; 50(7):758-63. PubMed ID: 7570411
[TBL] [Abstract][Full Text] [Related]
6. Systemic inflammation and the effects of short-term antibiotic treatment for PPM positive patients with stable COPD.
Wang JX; Li HQ; Zhang F; Ning W
Int J Chron Obstruct Pulmon Dis; 2019; 14():1923-1932. PubMed ID: 31692553
[TBL] [Abstract][Full Text] [Related]
7. Nemonoxacin achieved a better symptomatic improvement and a prolonged interval to next exacerbation than moxifloxacin for outpatients with acute exacerbations of chronic obstructive pulmonary disease.
Meng W; Zeng H; Zhao Z; Xiong R; Chen Y; Li Z
Sci Rep; 2023 Oct; 13(1):16954. PubMed ID: 37805617
[TBL] [Abstract][Full Text] [Related]
8. Chronic obstructive pulmonary disease: role of bacteria and guide to antibacterial selection in the older patient.
Murphy TF; Sethi S
Drugs Aging; 2002; 19(10):761-75. PubMed ID: 12390053
[TBL] [Abstract][Full Text] [Related]
9. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
Keam SJ; Keating GM
Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
[TBL] [Abstract][Full Text] [Related]
10. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
Beeh KM; Beier J; Candler H; Wittig T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515
[TBL] [Abstract][Full Text] [Related]
11. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
[TBL] [Abstract][Full Text] [Related]
12. Speed of recovery from acute exacerbations of chronic obstructive pulmonary disease after treatment with antimicrobials : results of a two-year study.
Miravitlles M; Zalacain R; Murio C; Ferrer M; Alvarez-Sala JL; Masa JF; Verea H; Ros F; Vidal R;
Clin Drug Investig; 2003; 23(7):439-50. PubMed ID: 17535055
[TBL] [Abstract][Full Text] [Related]
13. Effects of Pleuran (Β-Glucan from
Minov J; Bislimovska-Karadzhinska J; Petrova T; Vasilevska K; Stoleski S; Mijakoski D
Open Access Maced J Med Sci; 2017 Dec; 5(7):893-898. PubMed ID: 29362614
[TBL] [Abstract][Full Text] [Related]
14. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.
Seemungal TA; Donaldson GC; Bhowmik A; Jeffries DJ; Wedzicha JA
Am J Respir Crit Care Med; 2000 May; 161(5):1608-13. PubMed ID: 10806163
[TBL] [Abstract][Full Text] [Related]
15. Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis.
Wilson R; Allegra L; Huchon G; Izquierdo JL; Jones P; Schaberg T; Sagnier PP;
Chest; 2004 Mar; 125(3):953-64. PubMed ID: 15006954
[TBL] [Abstract][Full Text] [Related]
16. Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
Chodosh S; DeAbate CA; Haverstock D; Aneiro L; Church D
Respir Med; 2000 Jan; 94(1):18-27. PubMed ID: 10714475
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD.
Wilson R; Anzueto A; Miravitlles M; Arvis P; Haverstock D; Trajanovic M; Sethi S
Int J Chron Obstruct Pulmon Dis; 2015; 10():985-93. PubMed ID: 26082623
[TBL] [Abstract][Full Text] [Related]
18. Acute exacerbation of COPD: factors associated with poor treatment outcome.
Dewan NA; Rafique S; Kanwar B; Satpathy H; Ryschon K; Tillotson GS; Niederman MS
Chest; 2000 Mar; 117(3):662-71. PubMed ID: 10712989
[TBL] [Abstract][Full Text] [Related]
19. Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.
Blasi F; Schaberg T; Centanni S; Del Vecchio A; Rosignoli MT; Dionisio P
Pulm Pharmacol Ther; 2013 Oct; 26(5):609-16. PubMed ID: 23538168
[TBL] [Abstract][Full Text] [Related]
20. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
Ram FS; Rodriguez-Roisin R; Granados-Navarrete A; Garcia-Aymerich J; Barnes NC
Cochrane Database Syst Rev; 2006 Apr; (2):CD004403. PubMed ID: 16625602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
